OncoDaily
Onco
Daily
Twitter
Facebook
Youtube
RSS Feed
Linkedin
Facebook
RSS
Twitter
Youtube
Linkedin
August, 2024
August 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
« Jul
OncoDaily
Oct 28, 2023, 11:28 |
Career
Ruben Mesa: Dr. Nadine Barrett as Associate Director for Community Outreach and Engagement for Atrium Health Wake Forest Baptist Comprehensive Cancer Center
Ruben Mesa, President at Atrium Health Levine Cancer, made the following post on LinkedIn: "LEADERSHIP…
Oct 28, 2023, 03:09 |
Insight
Sandra Algarín-Perneth: The success of precision oncology guided by HER2 genomic profiling - a rare neuroendocrine carcinoma case
Sandra Algarín-Perneth, Postdoctoral Research Fellow in Gastroenterology and Hepatology at Mayo Clinic, shared on Twitter:…
Oct 28, 2023, 03:04 |
Opinion
Brigette Hyacinth: People are clamoring for a more human style of leadership
Brigette Hyacinth, Founder of Leadership EQ, recently posted on LinkedIn. "When kindness isn’t modeled in…
Oct 28, 2023, 01:34 |
Blog
Herbert Loong reflects on ESMO23
Herbert Loong, Clinical Associate Professor at The Chinese University of Hong Kong, recently posted on…
Oct 28, 2023, 01:25 |
Blog
The Breast Cancer Research Foundation (BCRF) announced $60.2 million commitment to fund breast cancer research in 2023-2024 - Yale Cancer Center
Yale Cancer Center recently posted on LinkedIn. "The Breast Cancer Research Foundation (BCRF) Scientific Advisory Board…
Oct 27, 2023, 17:13 |
Career
Andreas Charalambous: Guess who made it to the World’s Top 2% scientist list in the field of oncology nursing
Andreas Charalambous, President of the European Cancer Organisation, shared on LinkedIn: "Guess who made it…
Oct 27, 2023, 17:07 |
Blog
Brian Alexander: Honored to participate in the NCI's Combination Therapy Platform Trial with Molecular Analysis for Therapy Choice
Brian Alexander, CEO of Foundation Medicine, shared a post by Foundation Medicine on LinkedIn, adding;…
Oct 27, 2023, 17:01 |
Drugs
Revumenib in relapsed or refractory KMT2Ar acute leukemia - Syndax Pharmaceuticals
Nicole McNeer, Senior Medical Director and Clinical Leader at Syndax Pharmaceuticals, shared a post by…
Oct 27, 2023, 16:54 |
Blog
David Palma: Survey on patterns of practice for radiation oncologists
David Palma, Radiation Oncologist and Professor at Western University, shared on X/Twitter: "If you are…
Oct 27, 2023, 16:48 |
Stories
Katie Coleman: Looks like I’ve got a bladder polyp? lesion? growth? I named it Newman...
Katie Coleman, Founder of Chromophobe and Oncocytic Tumor Alliance (COA), shared on X/Twitter: "Looks like…
Oct 27, 2023, 13:35 |
Blog
Katie Coleman: Being young with cancer for me has meant a whole lot of clarifying, “No, I’m a patient.”
Katie Coleman, Founder of Chromophobe and Oncocytic Tumor Alliance (COA), shared on X/Twitter: "Being young…
Oct 27, 2023, 13:29 |
Blog
Guillermo Chantada: How did researchers survive the Valley of Death of publications?
Guillermo Chantada, President of the International Society of Paediatric Oncology (SIOP), shared a post by…
Oct 27, 2023, 04:48 |
Insight
Sumanta K. Pal: Eloquent discussion from Andrea Apolo National Cancer Institute synthesizing data from EV302 and CM901
Sumanta K. Pal, Co-Director of the City of Hope Kidney Cancer Program, posted on Twitter: "Eloquent…
Oct 27, 2023, 04:46 |
Opinion
Shikha Jain: Sometimes when with a patient, they don't need much more than your time...
Shikha Jain shared on Twitter: "Friendly reminder, sometimes when with a patient, they don't need much…
Oct 27, 2023, 04:45 |
Opinion
Mark Lewis: Oncologists should read this and re-evaluate their relationship with their pharmacy colleagues
Mark Lewis shared Kristen McCullough's post on Twitter, adding: "Oncologists should read this and re-evaluate their relationship…
Oct 27, 2023, 04:42 |
Career
Contribute to Cancer Research with Moffitt’s PhD Program in Cancer Chemical Biology
Moffitt Cancer Center shared on their LinkedIn: "Don't miss the opportunity to contribute to Cancer Research…
Oct 27, 2023, 04:38 |
Career
In a bipartisan vote, the Senate Committee on HELP advanced the nomination of Dr. Monica Bertagnolli as NIH Director
American Cancer Society Cancer Action Network announced on their LinkedIn: "Breaking: In a bipartisan vote, the…
Oct 27, 2023, 04:33 |
Blog
We were honoured to receive an award from our Community 365 contributors, ECO Foundation - European Cancer Organisation
European Cancer Organisation shared on LinkedIn: "This weekend, we were honoured to receive an award…
Oct 27, 2023, 04:23 |
Insight
The first randomised trial of a targeted agent versus immunotherapy plus chemotherapy in a biomarker-selected patient population - CUHK Medicine
CUHK Medicine shared on LinkedIn: " More than doubled lung cancer patients’ progression-free survival Lung…
Oct 27, 2023, 04:06 |
Insight
Joosje Baltussen: 64-76% of older patients treated with chemotherapy have poor outcomes after 1 year
Joosje Baltussen, Chair of Young SIOG (International Society of Geriatric Oncology) shared on LinkedIn: "Just…
Oct 27, 2023, 04:03 |
Blog
Rafael José Argüello: Setbacks are a part of life - they refine us, not define us
Rafael José Argüello, Assistant Researcher at The French National Centre for Scientific Research, shared on…
Oct 27, 2023, 03:53 |
Blog
Maite Gorostegui: Thank you Junious Sichali for sharing your experience with the families in Malawi
Maite Gorostegui, Chair of the SIOP Global Mapping Programme, shared a post by CANCaRe Africa…
Oct 27, 2023, 03:39 |
Insight
2023 edition recommendations for the Global Curriculum for Training in Medical Oncology - ESMO
Quoting the European Society for Medical Oncology (ESMO) on LinkedIn: "ESMO and the American Society…
Oct 26, 2023, 22:57 |
Opinion
Leonidas Platanias: Steven Rosenberg deserves the Nobel Prize for his incredible work in cancer immunotherapy
Leonidas Platanias, Director of the Lurie Comprehensive Cancer Center of Northwestern University, shared the following post…
Oct 26, 2023, 22:46 |
Insight
Daniel Flora: Promising data emerging from the BLUE-C colon cancer screening trial
Robin Zon, Director of Breast Oncology at Cincinnati Cancer Advisors, shared the following post by…
Oct 26, 2023, 22:32 |
Insight
Enrique Soto: The new ESMO and ASCO Global Curriculum in Medical Oncology is now online in Journal of European Society for Medical Oncology and JCO Global Oncology.
Enrique Soto, Medical Oncologist at the National Institute of Medical Science and Nutrition in Mexico…
Oct 26, 2023, 22:13 |
Blog
Millie Das elected President of the Association of Northern California Oncologists (ANCO) - Stanford Cancer Institute
Stanford Cancer Institute, posted the following on LinkedIn: "Congratulations to SCI member Millie Das, MD.…
Oct 26, 2023, 18:23 |
Blog
Ainhoa Madariaga: Happy to present at ESMO23 the results of MBOT the first app
Ainhoa Madariaga, Medical Oncologist at 12 Octubre University Hospital, shared on X/Twitter: "Happy to present…
Oct 26, 2023, 18:17 |
Blog
Teresa Amaral: Did you know that so far the data presented at ESMO23 made it to publications in the NEJM
Teresa Amaral, recently tweeted: "Did you know that so far the data presented at ESMO23…
Oct 26, 2023, 18:11 |
Blog
Amalya Sargsyan: It was a privilege to be part of the Grant writing school at Milano Bicocca
Amalya Sargsyan and Shushan Hovsepyan, Research Fellows at Immune Oncology Research Institute, shared a post by…
Oct 26, 2023, 18:04 |
Blog
Kunal Potnis: BiTE versus CAR-T for relapsed/refractory multiple myeloma at SMDM23 in Philadelphia
Kunal Potnis, Resident Physician at Yale New Haven Hospital, shared a post on X/Twitter: "Awesome…
Oct 26, 2023, 17:23 |
Blog
The Beginner Investigator Grants for Catalytic Research - American Association for Cancer Research
American Association for Cancer Research shared a post on LinkedIn: "The Beginner Investigator Grants for…
Oct 26, 2023, 17:00 |
Blog
Antibody–drug conjugates improve outcomes for patients with inoperable or metastatic Breast Cancer - European Society for Medical Oncology
ESMO - European Society for Medical Oncology shared a post on LinkedIn: "Antibody–drug conjugates improve…
Oct 26, 2023, 16:47 |
Blog
Bente Mikkelsen: Cancer in challenging times
Quoting Bente Mikkelsen, Director of the Non-Communicable Diseases Department at the World Health Organization, on…
Oct 26, 2023, 16:35 |
Blog
Estela Rodriguez: It’s not enough to hire more women in academia, we need to create a culture of opportunities/inclusions to make them stay
Estela Rodriguez shared a post by Katie Spoon on X/Twitter: "It’s not enough to hire…
Oct 26, 2023, 16:27 |
Blog
Benjamin Auberger: This major study naturally raises several questions
Quoting Benjamin Auberger, Oncologist at CHRU Brest, on LinkedIn: "A wow presidential session with a…
Oct 26, 2023, 16:21 |
Blog
Robin Zon: Thank you to the Hawaii Society of Clinical Oncology (HSCO) for a fabulous meeting - the Hawaii Society and the Governor are doing great things
Robin Zon, Director of Breast Oncology at Cincinnati Cancer Advisors, shared on LinkedIn: "Thank you…
Oct 26, 2023, 16:13 |
Blog
Bente Mikkelsen: Join us as we reflect on progress and lessons learned across three years of this historic movement
Bente Mikkelsen, Director NCD at World Health Organization, shared on LinkedIn: “On November 17th, World…
Oct 26, 2023, 16:06 |
Blog
Tracey O'Brien: Providing person-centred care with compassion and empathy is key to our work in cancer
Tracey O’Brien shared the following on LinkedIn: “Our health system has to be equipped to support…
Oct 26, 2023, 09:27 |
Opinion
Maurizio Scaltriti: What stands out at ESMO23 is the critical role that innovative trial design, early mechanistic studies and ongoing translational analysis play in informing treatment strategy
Oct 26, 2023, 09:21 |
Blog
Françoise Meunier commends ESMO's call to EU member states to protect cancer survivors from financial discrimination
Françoise Meunier, Founder of the European Initiative on Ending Discrimination Against Cancer Survivors, shared a…
Oct 26, 2023, 09:18 |
Blog
Vincent Rajkumar: After 20 years since inception, we got the final completion from CIRB today
Vincent Rajkumar, Editor in Chief of Blood Cancer Journal, posted on Twitter: "I’m really proud…
Oct 26, 2023, 09:14 |
Blog
Her Excellency Hajiya lami Ahmadu Umaru, flagged off free breast, cervical cancer screening and diagnosis for 1000 women in Adamawa State - First Ladies Against Cancer (FLAC)
Oct 26, 2023, 09:04 |
Blog
Jeremy Slone: Some highlights that stand out from SIOP 2023
Jeremy Slone recently posted on LinkedIn: "Last week, I attended the International Society of Paediatric Oncology…
Oct 26, 2023, 08:59 |
Blog
Rizine Mzikamanda: It is always intriguing and inspirational hearing and learning from others what work they are doing for Childhood Cancer
Rizine Mzikamanda, Pediatric Hematologist-Oncologist at Global HOPE Malawi, recently shared on LinkedIn: "Recently attended the…
Oct 25, 2023, 19:02 |
Insight
Amalya Sargsyan: ESMO23 - Advances in EGFR mutated NSCLC
Amalya Sargsyan, Research Fellow at Immune Oncology Research Institute, shared a post on LinkedIn: "ESMO23:…
Oct 25, 2023, 18:50 |
Blog
Emre Yekedüz: Our results including more than 20,000 patients were presented as a poster at ESMO23
Quoting Emre Yekedüz, Associate Professor of Medical Oncology at Ankara University, on X/Twitter: ''Our results…
Oct 25, 2023, 18:47 |
Blog
Mehra Golshan: Honored to be invited to the Japanese Society of Clinical Oncology 61st annual meeting as part of the JSCO/ASCO collaboration
Quoting Mehra Golshan, Executive Vice Chair for Operations; Department of Surgery at Yale School of Medicine,…
Oct 25, 2023, 18:45 |
Blog
Rong Fan: NCI symposium celebrating the 40 years of cancer epigenetic's
Quoting Rong Fan, Harold Hodgkinson Professor of Biomedical Engineering and Pathology at Yale University, on…
Oct 25, 2023, 18:37 |
Blog
Rob Winn: I stood on the shoulders of giants to get to this point at VCU Massey Comprehensive Cancer Center
Rob Winn, the Director of VCU Massey Cancer Center, shared a post by Luciana Vozza on…
Oct 25, 2023, 18:33 |
Blog
Uwe Platzbecker: He is a role model for how important patient participation and clinical trials are
Quoting Uwe Platzbecker, Head of Medical Department 1, Hematology and Cellular Therapy at Leipzig University,…
Oct 25, 2023, 18:29 |
Positive
Mariana Arnaut: The day you realize that the company you dreamed of building is real
Mariana Arnaut, Founder and CEO of The After Cancer, shared a post by The After…
Oct 25, 2023, 18:24 |
Blog
Svetlana Nikic on Breast Cancer Awareness Month: Help me in extending the awareness!
Quoting Svetlana Nikic, Founder of Precision Oncology Consulting, on LinkedIn: ''Breast Cancer Awareness Month. Breast…
Oct 25, 2023, 18:20 |
Blog
Angela Mastronuzzi: Our data strongly support the favourable therapeutic profile of PBT for the treatment of CNS germ cell tumors
Angela Mastronuzzi shared on LinkedIn: ''Our latest paper is out with Frontiers! "Unraveling the impact of…
Oct 25, 2023, 18:16 |
Blog
Ulrika Årehed Kågström reflects on World Cancer Leaders' Summit 2023
Quoting Ulrika Årehed Kågström on LinkedIn: ''Just returned home from participating in the World Cancer…
Oct 25, 2023, 18:13 |
Blog
Aradhana Sarin: Science + Finance = Innovation
Quoting Aradhana Sarin, Group CFO and Executive Director of AstraZeneca, on LinkedIn: ''Science + Finance =…
Oct 25, 2023, 18:09 |
Blog
Joanna Dodkins: Very excited to be presenting work conducted at the National Prostate Cancer Audit
Joanna Dodkins, Clinical oncology registrar at Guy's Hospital, London, shared on her Twitter: "Very excited to…
Oct 25, 2023, 18:04 |
Insight
Talha Badar: Moving immunotherapy upfront in B-cell ALL
Talha Badar, Assistant Professor of Oncology at Mayo Clinic Comprehensive Cancer Center, posted on Twitter:…
Oct 25, 2023, 17:57 |
Insight
Tian Zhang: Discussed by Sandhu Shahneen — we should likely wait for PSA recurrence before salvage radiation
Tian Zhang recently shared on Twitter: "RADICALS-HD showed a definitive equivalence in survival for adjuvant…
Oct 25, 2023, 17:52 |
Insight
Ilya Tsimafeyeu: Patients with metastatic renal cell carcinoma and high fibrinogen levels who received nivolumab had worse overall survival
Ilya Tsimafeyeu, Director at Bureau of Cancer Research Russia, shared on Facebook: "Our study: Patients…
Oct 25, 2023, 17:44 |
Drugs
Nicolas Hubacz: Top Selling Pharmaceuticals of 2023
Nicolas Hubacz shared on LinkedIn: "Top Selling Pharmaceuticals of 2023. As the COVID-19 pandemic's grip…
Oct 25, 2023, 17:36 |
Blog
Naveen Pemmaraju: Shout out to my fellow co-founding moderators for the successful first-in-person MPN Co&D meeting in Paris.
Naveen Pemmaraju shared on Twitter: "Shout out to my fellow co-founding moderators for the successful…
Oct 25, 2023, 17:30 |
Blog
Russell Conley: I’m so pleased to be back working at the GI Cancer Institute following my cancer treatment
Russell Conley, Chief Executive Officer at GI Cancer Institute, shared on LinkedIn: "I’m so pleased…
Oct 25, 2023, 17:27 |
Insight
Tom Powles: TAR-210 releases Erdafitinib slowly into the bladder by a novel release system
Tom Powles, Director of Barts Cancer Centre, shared on Twitter: ''Something NEW. TAR-210 releases Erdafitinib…
Oct 25, 2023, 17:23 |
Insight
Ishwaria Subbiah: If life’s in the journey and not the endpoint, then preparing our patients and caregivers for the EVP journey is the top priority!
Ishwaria Subbiah shared on Twitter: "Wow! That OS w EVP! This wait for approval is…
Oct 24, 2023, 20:07 |
Blog
Svetlana Nikic: When we think about innovations in precision oncology, who wins? Commercial drivers or clinical unmet need?
Svetlana Nikic, Founder of Precision Oncology Consulting, made the following post on LinkedIn: "Very interesting…
Oct 24, 2023, 19:58 |
Blog
Elizabeth Plimack: Kudos to Amanda Nizam for winning Best ESMO2023 Poster in Urothelial
Elizabeth Plimack, Deputy Director Fox Chase Cancer Center, made the following post on Twitter: "Kudos…
Oct 24, 2023, 19:50 |
Blog
Announcing the ASCO Quality Care Symposium 2023 Featured Voices! - ASCO
American Society of Clinical Oncology (ASCO) posted the following on Twitter: "Announcing the ASCO Quality…
Oct 24, 2023, 16:16 |
Blog
Caroline Markham: Coming to ESMO23 is about meeting new societies and strengthening relationships with existing partners
Caroline Markham, Head of Strategic Partnerships at Touch Medical Media Services Ltd., shared on her LinkedIn…
Oct 24, 2023, 16:09 |
Societies
ESMO congratulates the recipients of the 2023 Research Fellowships and the José Baselga Fellowship
ESMO posted on their Twitter page: "ESMO congratulates the recipients of the 2023 Research Fellowships…
Oct 24, 2023, 16:02 |
Opinion
Belén Garijo: This old mechanical calculator illustrates two things about how we should think about Generative AI today
Belén Garijo shared on LinkedIn: "For 355 years, Merck Group has pushed the boundaries of human progress with the best…
Oct 24, 2023, 15:57 |
Blog
Kathrin Heinrich: Why is there no applause for this KM-curve…?
Kathrin Heinrich, Doctor at the Ludwig Maximilian University Hospital, Munich, recently tweeted: "Why is there no…
Oct 24, 2023, 15:50 |
Blog
Caroline Markham: Thank you to both Dr. Lena Sharpe and Helena Ullgren for meeting with me at EONS16 to discuss the success of the PrEvCan campaign
Caroline Markham, Head of Strategic Partnerships at Touch Medical Media Services Ltd., recently posted on…
Oct 24, 2023, 15:49 |
Blog
Benedikt Westphalen: First results of CUPISCO presented at ESMO23
Quoting Benedikt Westphalen, Medical Lead Precision Oncology, on X/Twitter: "First results of CUPISCO presented at…
Oct 24, 2023, 15:47 |
Blog
Eddy Carolina Pedraza S.: Reflecting on the wonderful and inspiring time we shared at SIOP 2023 in Ottawa.
Quoting Eddy Carolina Pedraza S., PhD Candidate in Health Sciences - University of Lucerne Switzerland,…
Oct 24, 2023, 15:38 |
Opinion
The Max Foundation: Pat Garcia-Gonzalez was recognized and awarded by the President of Kenya, William Samoei Ruto, in honor of Mashujaa Day
Pat Garcia-Gonzalez, Chief Executive Officer at The Max Foundation, recently shared a post by The…
Oct 24, 2023, 15:36 |
Blog
Lucjan Wyrwicz: Grab the most recent issue of the Lancet Oncology with the full report of the Keynote-859 study
Lucjan Wyrwicz, Professor at the National Institute of Oncology Maria Skłodowska-Curie - National Research Institute,…
Oct 24, 2023, 15:29 |
Blog
Deniz Can Guven: We got the best poster award for palliative care
Deniz Can Guven, Medical Oncologist at Health Sciences University, recently shared on X/Twitter: "ESMO2023 excitement is…
Oct 24, 2023, 15:25 |
Blog
Lauren Meehan Machos: First combination therapy
Lauren Meehan Machos, Oncology Opinion Leader Liaison - Renal, Lung, Immuno-Oncology at Pfizer, recently shared…
Oct 24, 2023, 15:24 |
Dialogues
5 min OncoDaily Updates with Chandler Park: Petros Grivas on the patient advocacy groups
[embed]https://www.youtube.com/watch?v=Ap9VbtYaz4o[/embed]
Oct 24, 2023, 15:21 |
Blog
Over a 20-year period this could save 2.5 million lives - Union for International Cancer Control (UICC)
Quoting Union for International Cancer Control (UICC) on LinkedIn: "Breast cancer is the most common…
Oct 24, 2023, 15:16 |
Blog
Erika Hamilton: Often times when people consider the hardship or "cost" of cancer and chemotherapy, these things are forgotten
Erika Hamilton shared on LinkedIn: "This is huge. Often times when people consider the hardship…
Oct 24, 2023, 15:05 |
Blog
Clélia-Elsa Froguel: Great session at ESMO2023 on National and regional cancer strategies
Quoting Clélia-Elsa Froguel, International Director of Evoke Incisive Health, on LinkedIn: "Great session at ESMO2023…
Oct 24, 2023, 14:57 |
Blog
ESMO updates from Presidential Symposium- European Society for Medical Oncology (ESMO)
European Society for Medical Oncology (ESMO) shared on LinkedIn: "Positive outcomes in advanced or metastatic…
Oct 24, 2023, 14:05 |
Drugs
Agenus is proud to unveil the latest research from our investigational botensilimab programs - Agenus
Agenus shared a post on LinkedIn: "Agenus is proud to unveil the latest research from…
Oct 24, 2023, 13:53 |
Blog
Runcie C.W. Chidebe: If you are looking for inspiration, here is it.
Runcie C.W. Chidebe, Executive Director at Project PINK BLUE, shared a post on LinkedIn: "If…
Oct 24, 2023, 13:52 |
Blog
So grateful to have you had with us and to meet again - Advanced Oncology
Advanced Oncology shared a post on LinkedIn: "It has been 10 years that Dr Rehab…
Oct 24, 2023, 13:49 |
Opinion
Flavia Jacobs: At ESMO23 we presented the results of our systematic review and meta-analysis evaluating PFS by central vs. local assessment in randomized clinical trials in metastatic breast cancer
Oct 24, 2023, 13:48 |
Blog
Toni Choueiri: Dr. Arlene Siefker-Radtkr presents the results of THOR
Quoting Toni Choueiri, the Director of the Lank Center for Genitourinary (GU) Oncology at Dana-Farber Cancer Institute, on…
Oct 24, 2023, 13:46 |
Blog
Navneet Singh: Thank you very much Peters Solange and ESMO for enabling me to virtually attend this important meeting
Navneet Singh, Thoracic Oncologist and Professor at Postgraduate Institute of Medical Education and Research, Chandigarh,…
Oct 24, 2023, 13:45 |
Blog
Stephen V Liu: ESMO23 - Dr. Solange Peters presents the PERLA randomized phase II study
Quoting Stephen V Liu, Associate Professor of Medicine and the Director of Thoracic Oncology at Georgetown University,…
Oct 24, 2023, 13:44 |
Insight
MD Anderson-led global Phase III study finds that a PARP inhibitor plus immunotherapy lowers the risk of endometrial cancer progression over chemotherapy alone - MD Anderson Cancer Center
Oct 24, 2023, 13:43 |
Blog
Brigette Hyacinth: The future lies in flexible work patterns
Quoting Brigette Hyacinth, Author and Keynote Speaker on Leadership, HR and AI, on LinkedIn: "My…
Oct 24, 2023, 13:41 |
Blog
WHO recognizes the potential of Artificial Intelligence in enhancing Health For All - World Health Organization
The World Health Organization shared on LinkedIn: "WHO recognizes the potential of Artificial Intelligence in…
Oct 24, 2023, 13:40 |
Positive
Mike Linn: PET came back clean - I remain cancer-free!
Quoting Mike Linn, Cancer Patient Advocate, on X/Twitter: "PET came back clean - I remain…
Oct 23, 2023, 23:31 |
Blog
Douglas Flora: What a surreal and powerful experience visiting the headquarters of Mary Ann Liebert, Inc. and interacting with the incredible AIPO team
Douglas Flora, Executive Medical Director and Editor-in-Chief of AI in Precision Oncology, made the following…
Oct 23, 2023, 23:15 |
Blog
Christine Lovly: So proud to say Portia completed her PhD in my lab studying B7-H6 as an immune target in small cell Lung Cancer
Christine Lovly, Thoracic Oncologist & Physician Scientist at Vanderbilt University Medical Center, shared the following…
Oct 23, 2023, 22:57 |
Blog
Thanking ESMO23 Social Media Ambassadors for their enthusiastic reporting from the Congress - The European Society for Medical Oncology
The European Society for Medical Oncology, made the following post on Twitter: "Thanking ESMO23 Social…
Oct 23, 2023, 17:33 |
Blog
Olubukola Ayodele: So proud of 2 of my specialist registrars who are attending ESMO congress for the first time
Olubukola Ayodele, Consultant Medical Oncologist at University Hospitals of Leicester NHS Trust, shared a post…
Oct 23, 2023, 17:31 |
Blog
Recipients of the My Child Matters Nurses Award - Foundation S
Foundation S shared a post on LinkedIn: "Time to congratulate. Last week at the International…
137
138
139
140
141
All:
16186
Posts:
13801 - 13900
Why does Lionel Messi donate so much to charity?
The largest philanthropic partnership in The V Foundation’s history - Dolphins Cancer Challenge
Glecirasib: A Promising Novel KRAS G12C Inhibitor in Clinical Development
How the Médecins Sans Frontières Journal Inspired a Lifetime of Humanitarian Service: Paul Spiegel
OncoDaily Party and Yvonne Award Photos - Part 1
Facebook
RSS Feed
Twitter
Linkedin
Youtube